Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry

Heidi Tiller, Marije M Kamphuis, Olof Flodmark, Nikos Papadogiannakis, Anna L David, Susanna Sainio, Sinikka Koskinen, Kaija Javela, Agneta Taune Wikman, Riitta Kekomaki, Humphrey H H Kanhai, Dick Oepkes, Anne Husebekk, Magnus Westgren, Heidi Tiller, Marije M Kamphuis, Olof Flodmark, Nikos Papadogiannakis, Anna L David, Susanna Sainio, Sinikka Koskinen, Kaija Javela, Agneta Taune Wikman, Riitta Kekomaki, Humphrey H H Kanhai, Dick Oepkes, Anne Husebekk, Magnus Westgren

Abstract

Objective: To characterise pregnancies where the fetus or neonate was diagnosed with fetal and neonatal alloimmune thrombocytopenia (FNAIT) and suffered from intracranial haemorrhage (ICH), with special focus on time of bleeding onset.

Design: Observational cohort study of all recorded cases of ICH caused by FNAIT from the international No IntraCranial Haemorrhage (NOICH) registry during the period 2001-2010.

Setting: 13 tertiary referral centres from nine countries across the world.

Participants: 37 mothers and 43 children of FNAIT pregnancies complicated by fetal or neonatal ICH identified from the NOICH registry was included if FNAIT diagnosis and ICH was confirmed.

Primary and secondary outcome measures: Gestational age at onset of ICH, type of ICH and clinical outcome of ICH were the primary outcome measures. General maternal and neonatal characteristics of pregnancies complicated by fetal/neonatal ICH were secondary outcome measures.

Results: From a total of 592 FNAIT cases in the registry, 43 confirmed cases of ICH due to FNAIT were included in the study. The majority of bleedings (23/43, 54%) occurred before 28 gestational weeks and often affected the first born child (27/43, 63%). One-third (35%) of the children died within 4 days after delivery. 23 (53%) children survived with severe neurological disabilities and only 5 (12%) were alive and well at time of discharge. Antenatal treatment was not given in most (91%) cases of fetal/neonatal ICH.

Conclusions: ICH caused by FNAIT often occurs during second trimester and the clinical outcome is poor. In order to prevent ICH caused by FNAIT, at-risk pregnancies must be identified and prevention and/or interventions should start early in the second trimester.

Figures

Figure 1
Figure 1
Flow diagram of the study population.
Figure 2
Figure 2
Estimated time period for the onset of intracranial haemorrhage (ICH) is shown for 41 cases of ICH caused by fetal and neonatal alloimmune thrombocytopenia. An arrowhead to the left indicates that the earliest time of onset cannot be estimated, only that the bleeding occurred before the gestational age indicated on the x-axis.
Figure 3
Figure 3
(A) CT scan shows a very large intraparenchymal haemorrhage with mass effect and occupying most of the right frontal lobe in a term baby. Note a second but smaller haemorrhage on the left side adjacent to the ventricle but separate from this. The attenuation of both haemorrhages indicates that the haemorrhage is several weeks old at the time of imaging. We estimated the right haemorrhage to be 4–6 weeks old and the left still a couple of weeks older. The pregnancy was considered normal, and no intravenous immunoglobulin treatment was given. A live boy was born vaginally at 40 gestational weeks with petecchiae. The platelet count was 6×109/l. (B) This CT shows marked ventriculomegaly, partly due to hydrocephalus, partly due to loss of brain tissue in the left hemisphere. Note the very large ventricle on the left side occupying most of the left hemicranium. The shape of the left lateral ventricle is irregular and that of residual from a previous intraventricular haemorrhage with a paraventricular atrophic defect caused by an old periventricular haemorrhagic infarction. This pattern is pathognomonic for this condition even though no actual blood can be detected. The interpretation of this image is that of an intraventricular haemorrhage associated with a periventricular haemorrhagic infarction timed at 28–30 gestational weeks or earlier. Hydrocephalus was diagnosed intrapartum because of breech presentation. A live boy was born at term with a platelet count of 4×109/l. The child had severe cerebral palsy and a hydrocephalus shunt. (C) The CT scan shows multiple focal intraparenchymal haemorrhages throughout both cerebral hemispheres. Most haemorrhages are quite small. Note also the extensive extracranial subgaleal haemorrhage overlying the right hemicranium. All bleedings are of same age and maximum 7 days old. It was noted that the fetus was small on ultrasound scan at 25 weeks, but otherwise the pregnancy was considered normal. At 42 weeks a live boy was born vaginally, with multiple petecchiaes and multiple retinal bleedings. The platelet count at delivery was 14×109/l, with nadir value 8×109/l. He received platelet transfusions. At time of discharge the boy was described as alive and well, but we do not have data on long-term clinical outcome.

References

    1. Mao C, Guo J, Chituwo BM. Intraventricular haemorrhage and its prognosis, prevention and treatment in term infants. J Trop Pediatr 1999;45:237–40
    1. Williamson LM, Hackett G, Rennie J, et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998;92:2280–7
    1. Kamphuis MM, Paridaans N, Porcelijn L, et al. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. BJOG 2010;117:1335–43
    1. Jocelyn LJ, Casiro OG. Neurodevelopmental outcome of term infants with intraventricular hemorrhage. Am J Dis Child 1992;146:194–7
    1. Radder CM, Brand A, Kanhai HH. Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? Vox Sang 2003;84:318–25
    1. Kamphuis MM, Oepkes D. Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions. Prenat Diagn 2011;31:712–19
    1. Kanhai HH, Porcelijn L, Engelfriet CP, et al. Management of alloimmune thrombocytopenia. Vox Sang 2007;93:370–85
    1. Pacheco LD, Berkowitz RL, Moise KJ, et al. Fetal and neonatal alloimmune thrombocytopenia. A management algorithm based on risk stratification. Obstet Gynecol 2012;118:1157–63
    1. Osborn AG. Imaging of intracranial hemorrhage. Diagnostic neuroradiology. St Louis: Mosby, 1994:158–73
    1. Bax M, Tydeman C, Flodmark O. Clinical and MRI correlates of cerebral palsy. JAMA 2012;296:1602–8
    1. Kiefel V, Santoso S, Weisheit M, et al. Monoclonal antibody—specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722–6
    1. Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001;41:45–55
    1. Bussel JB, Berkowitz RL, Hung C, et al. Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. Am J Obstet Gynecol 2010;203:135–14
    1. Tiller H, Killie MK, Skogen B, et al. Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys. Acta Obstet Gynecol Scand 2011;91:79–86
    1. Kjeldsen-Kragh J, Killie MK, Tomter G, et al. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007;110:833–9
    1. Kjeldsen-Kragh J, Ni H, Skogen B. Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia. Curr Opin Hematol 2012;19:469–74
    1. Tiller H, Killie MK, Chen P, et al. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model. Transfusion 2012;52:1446–57
    1. van den AE, Oepkes D, Brand A, et al. Vaginal delivery for fetuses at risk of alloimmune thrombocytopenia? BJOG 2006;113:781–3

Source: PubMed

3
Abonneren